�������ýҕ�l

Governments and companies are planning to introduce mobile applications that use Bluetooth to track coronavirus infections. Researchers say the technology keeps users’ identifying data private, but the complexity of working with Bluetooth raises cybersecurity concerns. Bluetooth, a widely used technology for connecting devices, has emerged as the technology of choice for tracking the spread of the coronavirus, as the U.S. and European countries decide how to safely reopen businesses in the coming weeks and months. (Stupp, 4/30)

After a review of the aging physical and information-technology infrastructure at Mann-Grandstaff VA Medical Center, the OIG determined that the "VA committed to an aggressive, but likely unrealistic, deployment date of March 2020 without having the necessary information on the state of the medical center's infrastructure," according to the report. That's on top of challenges posed by anticipated EHR capabilities—such as online prescription refill— not being ready by the March go-live date, according to a separate report the OIG released this week. (Cohen, 4/29)

Kaiser Health News: As Coronavirus Strikes, Crucial Data In Electronic Health Records Hard To Harvest

When President Donald Trump started touting hydroxychloroquine as “one of the biggest game changers” for treating COVID-19, researchers hoped electronic health records could quickly tell them if he was on the right track. Yet pooling data from the digital records systems in thousands of hospitals has proved a technical nightmare thus far. That’s largely because software built by rival technology firms often cannot retrieve and share information to help doctors judge which coronavirus treatments are helping patients recover. (Schulte, 4/30)

Teladoc Health reported $180.8 million in revenue for this year's first quarter, up 41% from $128.6 million posted in the year-ago quarter. That meant Teladoc beat its own revenue guidance for the quarter by multiple millions of dollars, as telemedicine use has soared in the wake of the COVID-19 outbreak. In February, the Purchase, N.Y.-based telemedicine provider had said it expected its revenue for the quarter to be in the range of $169 million to $172 million. (Cohen, 4/29)